thrombin receptor peptide sfllrnp and apixaban

thrombin receptor peptide sfllrnp has been researched along with apixaban in 1 studies

Compound Research Comparison

Studies (thrombin receptor peptide sfllrnp)	Trials (thrombin receptor peptide sfllrnp)	Recent Studies (post-2010) (thrombin receptor peptide sfllrnp)	Studies (apixaban)	Trials (apixaban)	Recent Studies (post-2010) (apixaban)
92	10	29	2,405	255	2,250

Protein Interaction Comparison

Protein	Taxonomy	thrombin receptor peptide sfllrnp (IC50)	apixaban (IC50)
Coagulation factor X	Homo sapiens (human)		0.22

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ivankova, J; Kovar, F; Mokan, M; Nehaj, F; Sokol, J; Stasko, J	1

Trials

1 trial(s) available for thrombin receptor peptide sfllrnp and apixaban

Article	Year
First Evidence: TRAP-Induced Platelet Aggregation Is Reduced in Patients Receiving Xabans. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2018, Volume: 24, Issue:6 Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Female; Humans; Male; Middle Aged; Peptide Fragments; Platelet Aggregation; Platelet Function Tests; Pyrazoles; Pyridones; Rivaroxaban; Time Factors	2018

Article

Year

First Evidence: TRAP-Induced Platelet Aggregation Is Reduced in Patients Receiving Xabans.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2018, Volume: 24, Issue:6

Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Female; Humans; Male; Middle Aged; Peptide Fragments; Platelet Aggregation; Platelet Function Tests; Pyrazoles; Pyridones; Rivaroxaban; Time Factors

2018